Virginia E. Rivero

2.1k total citations
64 papers, 1.6k citations indexed

About

Virginia E. Rivero is a scholar working on Immunology, Urology and Microbiology. According to data from OpenAlex, Virginia E. Rivero has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 18 papers in Urology and 14 papers in Microbiology. Recurrent topics in Virginia E. Rivero's work include Urinary Bladder and Prostate Research (16 papers), Reproductive tract infections research (14 papers) and Sperm and Testicular Function (11 papers). Virginia E. Rivero is often cited by papers focused on Urinary Bladder and Prostate Research (16 papers), Reproductive tract infections research (14 papers) and Sperm and Testicular Function (11 papers). Virginia E. Rivero collaborates with scholars based in Argentina, Belgium and Germany. Virginia E. Rivero's co-authors include Rubén D. Motrich, Mariana Maccioni, Clelia M. Riera, María Laura Breser, Juan Pablo Mackern‐Oberti, Gerardo Gatti, Rosa Isabel Molina, Andrea Tissera, Cecilia Cuffini and Virginia Andreani and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Virginia E. Rivero

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia E. Rivero Argentina 26 530 471 250 233 211 64 1.6k
Ingrid Ehrén Sweden 17 494 0.9× 208 0.4× 268 1.1× 30 0.1× 288 1.4× 31 1.3k
Sudhanshu Bhushan Germany 26 93 0.2× 816 1.7× 58 0.2× 830 3.6× 421 2.0× 59 1.9k
Roberto Ferrarese Italy 19 57 0.1× 216 0.5× 52 0.2× 79 0.3× 880 4.2× 36 1.6k
Mohammad Ali Sadighi Gilani Iran 22 67 0.1× 97 0.2× 53 0.2× 844 3.6× 412 2.0× 99 1.4k
Mario Salmeri Italy 19 38 0.1× 97 0.2× 110 0.4× 162 0.7× 414 2.0× 50 1.2k
Livia Lustig Argentina 28 72 0.1× 881 1.9× 15 0.1× 1.0k 4.5× 380 1.8× 55 2.0k
Pınar Gümüş Türkiye 19 86 0.2× 145 0.3× 27 0.1× 33 0.1× 298 1.4× 39 1.3k
Tülay Yucel‐Lindberg Sweden 31 103 0.2× 415 0.9× 113 0.5× 6 0.0× 727 3.4× 98 3.4k
Márjorie de Assis Golim Brazil 22 112 0.2× 168 0.4× 19 0.1× 23 0.1× 223 1.1× 107 1.5k
Wim Calame Netherlands 22 15 0.0× 370 0.8× 162 0.6× 18 0.1× 395 1.9× 57 2.0k

Countries citing papers authored by Virginia E. Rivero

Since Specialization
Citations

This map shows the geographic impact of Virginia E. Rivero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia E. Rivero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia E. Rivero more than expected).

Fields of papers citing papers by Virginia E. Rivero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia E. Rivero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia E. Rivero. The network helps show where Virginia E. Rivero may publish in the future.

Co-authorship network of co-authors of Virginia E. Rivero

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia E. Rivero. A scholar is included among the top collaborators of Virginia E. Rivero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia E. Rivero. Virginia E. Rivero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Martínez, Maria Santos, et al.. (2024). CD8 T cells are dispensable for experimental autoimmune prostatitis induction and chronic pelvic pain development. Frontiers in Immunology. 15. 1387142–1387142. 2 indexed citations
3.
Tissera, Andrea, et al.. (2024). Impact of high-risk and low-risk human papillomavirus infections on the male genital tract: effects on semen inflammation and sperm quality. Frontiers in Cellular and Infection Microbiology. 14. 1420307–1420307. 3 indexed citations
4.
Tissera, Andrea, et al.. (2023). Chronic epididymitis due to Chlamydia trachomatis LGV-L2 in an HIV-negative heterosexual patient: a case report. Frontiers in Public Health. 11. 1129166–1129166. 1 indexed citations
5.
Rivero, Virginia E., et al.. (2023). COVID-19 associates with semen inflammation and sperm quality impairment that reverses in the short term after disease recovery. Frontiers in Physiology. 14. 1220048–1220048. 10 indexed citations
6.
Martínez, Maria Santos, et al.. (2023). Expression of HPV-16 E6 and E7 oncoproteins alters Chlamydia trachomatis developmental cycle and induces increased levels of immune regulatory molecules. Frontiers in Cellular and Infection Microbiology. 13. 1214017–1214017. 2 indexed citations
7.
Molina, Rosa Isabel, et al.. (2021). Association between Human Papillomavirus and Chlamydia trachomatis genital infections in male partners of infertile couples. Scientific Reports. 11(1). 19924–19924. 11 indexed citations
8.
9.
Breser, María Laura, Luciana Paola Bohl, María Soledad Orellano, et al.. (2018). Chitosan and cloxacillin combination improve antibiotic efficacy against different lifestyle of coagulase-negative Staphylococcus isolates from chronic bovine mastitis. Scientific Reports. 8(1). 5081–5081. 33 indexed citations
10.
Korf, Hannelie, María Laura Breser, Jelter Van Hoeck, et al.. (2017). MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset. PLoS ONE. 12(11). e0187455–e0187455. 15 indexed citations
11.
12.
Gatti, Gerardo, et al.. (2014). Bio-efficacy of the Essential Oil of Oregano (Origanum vulgare Lamiaceae. Ssp. Hirtum). Plant Foods for Human Nutrition. 69(4). 351–357. 31 indexed citations
13.
Núñez, Nicolás Gonzalo, Virginia Andreani, María Inés Crespo, et al.. (2011). IFNβ Produced by TLR4-Activated Tumor Cells Is Involved in Improving the Antitumoral Immune Response. Cancer Research. 72(3). 592–603. 41 indexed citations
14.
Mackern‐Oberti, Juan Pablo, María Laura Breser, Nicolás Gonzalo Núñez, et al.. (2011). Chemokine response induced by Chlamydia trachomatis in prostate derived CD45+ and CD45− cells. Reproduction. 142(3). 427–437. 15 indexed citations
15.
Andreani, Virginia, et al.. (2007). Activation of Toll-like Receptor 4 on Tumor Cells In vitro Inhibits Subsequent Tumor Growth In vivo. Cancer Research. 67(21). 10519–10527. 63 indexed citations
16.
Motrich, Rubén D., Mariana Maccioni, Clelia M. Riera, & Virginia E. Rivero. (2007). Autoimmune Prostatitis: State of the Art. Scandinavian Journal of Immunology. 66(2-3). 217–227. 66 indexed citations
17.
Motrich, Rubén D., et al.. (2006). Uric acid crystals in the semen of a patient with symptoms of chronic prostatitis. Fertility and Sterility. 85(3). 751.e1–751.e4. 9 indexed citations
18.
Motrich, Rubén D., Mariana Maccioni, Rosa Isabel Molina, et al.. (2005). Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens. Human Reproduction. 20(9). 2567–2572. 53 indexed citations
19.
Maccioni, Mariana, et al.. (2003). Effect of Prostatein, the Major Protein Produced by the Rat Ventral Prostate, on Phagocytic Cell Functions. American Journal of Reproductive Immunology. 50(6). 473–480. 10 indexed citations
20.
Correa, Silvia G., et al.. (1993). Effect of Gangliosides in the Autoimmune Response Induced by Liposome-Associated Antigens. Autoimmunity. 15(3). 195–200. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingrid Ehrén Breakdown of academic impact, for papers by Sudhanshu Bhushan Breakdown of academic impact, for papers by Roberto Ferrarese Breakdown of academic impact, for papers by Mohammad Ali Sadighi Gilani Breakdown of academic impact, for papers by Mario Salmeri Breakdown of academic impact, for papers by Livia Lustig Breakdown of academic impact, for papers by Pınar Gümüş Breakdown of academic impact, for papers by Tülay Yucel‐Lindberg Breakdown of academic impact, for papers by Márjorie de Assis Golim Breakdown of academic impact, for papers by Wim Calame
Rankless by CCL
2026